CrossrefInfokarte
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology · 2008-05-01 · 3 (2) · 132-143
DOI: 10.2174/157488408784293705 ↗Abstract
Kein Abstract verfügbar.
EUVIMED